We’re on a mission to enable effective therapies to people faster.
A novel approach to research
For the past two decades clinical research has been hindered by outdated processes and technologies leaving millions without treatments.
After struggling to access patients in her own research in rare skin diseases, Dr. Michelle Longmire set out to solve this long-standing challenge in research.
Drawing inspiration from innovation and technological advancements in other industries, Longmire rallied stakeholders, partners, and developers to launch our company, Medable, with the shared vision of radically increasing the number of effective therapies to people each year.
Committed to science. Powered by innovation.
In order to achieve this vision, we needed to amplify the quality, reach, velocity, and cost of research.
Driven by the belief that clinical research can and should be better, we've assembled world-class scientific and product teams to continuously drive evidence-based improvements to the trial experience for all.
The relentless pursuit of progress, together.
Human connection is at the heart of everything we do. We prioritize the personal experience of patients, caregivers, knowing that their knowledge and feedback are essential to improving clinical research. In close partnership with with our network of sites, we continuously improve our platform, because we know that when they win, we all win. By designing products that are more accessible and user-friendly, we can bring life-change treatments to those who need them faster.
Together, with our clients and partners, we continue to work toward our mission and drive clinical research forward for the betterment of all.
Accolades
The latest from Medable
Why cloud-based eCOA software is becoming the industry standard
The landscape of clinical trials is evolving rapidly, and at the forefront of this transformation is eCOA (electronic Clinical Outcome Assessment) software. This technology is streamlining data collection, enhancing patient compliance, and ensuring regulatory adherence like never before.
Medable Studio Showcase
More than an eCOA builder, Medable Studio’s simple point and click interface brings total control and transparency to the study launch process.
Demo On Demand: eCOA+, patient & site experiences, and pulse oximeter sensor
VP of Solution Consulting, Jess Dolphi, showcases a few of the platform’s features, including site experience, patient experience, data and oversight dashboards, and a demonstration of connecting a pulse oximeter sensor for remote data capture.
New Data Reveals DCT Components Linked to Improvements in Clinical Trial Access Among Underrepresented Communities
Medable's groundbreaking study with the Tufts PACT Consortium highlights the transformative impact of decentralized clinical trials (DCTs) on diversity.
Medable Joins Forces with Google Cloud to Deliver Digital Clinical Trials Technology on Google Cloud Marketplace
Medable, a leading provider of clinical development technology, today announced a collaboration with Google Cloud to bring Medable’s Digital andDecentralized Clinical Trial Platform to Google Cloud Marketplace.
New Medable Studio Empowers Sponsors to Launch eCOA Solutions into Clinical Trials with Unparalleled Control and Efficiency
Medable Studio for eCOA nowavailable; two top-10 pharma company early adopters